Evotec up 7% in early trade after 9-month revenue, earnings beat

Evotec SE

14/10/2026 07:09

** Evotec's EVTG.DE shares are up around 7% in early Frankfurt trade after the German drug discovery company's preliminary nine-month results topped expectations
** The company said on Tuesday it expected 9-month group revenues of about €465.0 million, with adjusted group EBITDA of about -€42.8 million
** That compares with consensus view of €429 million for revenue and adjusted EBITDA of -€45 million, a local trader says
     

(Reporting by Anastasiia Kozlova)
((Anastasiia.Kozlova@thomsonreuters.com))